Company:  HEAT BIOLOGICS, INC. (HTBX)
Form Type:  8-K/A
Filing Date:  7/17/2017 
CIK:  0001476963 
Address:  801 CAPITOLA DRIVE 
City, State, Zip:  DURHAM, North Carolina 27713 
Telephone:  919-240-7133 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.44  
Change: 
-0.0135 (-2.98%)  
Trade Time: 
11:59 AM EST  
Market Cap: 
$15.75M
Trade HTBX now with 

© 2017  
Description of Business
We are an immuno-oncology company developing novel therapies designed to activate a patient's immune system against cancer utilizing an engineered form of gp96. Heat's highly specific T cell-stimulating therapeutic vaccine platform technologies, ImPACT® (Immune Pan-Antigen Cytotoxic Therapy) and ComPACT(TM) (Combination Pan-Antigen Cytotoxic Therapy), form the basis of our product candidates. Our platform technologies address two synergistic mechanisms of action: activation and proliferation of CD8+ T cells, or "killer" T cells; and T cell co-stimulation. We believe the use of these technologies in combination with other immunotherapies has the potential to dramatically improve patient outcomes.
Register and access this filing in:     
  FORM 8-K/A
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.03 - Material Modification to Rights of Security Holders.
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.03 - Amendments to Articles of Incorporation or ...
      Item 5.07 - Submission of Matters to a Vote of Security Holders.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 - Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 3.1
    CERTIFICATE OF INCORPORATION